+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient



Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient



Transplant Infectious Disease 7(2): 71-74



Congenital cytomegalovirus (CMV) infection occurs in approximately 1% of newborns and is the leading infectious cause of congenital birth defects. Female renal allograft recipients who develop CMV infection during pregnancy are at risk for both graft dysfunction and fetal morbidity. DNA-based analysis of amniotic fluid (AF) from at-risk pregnancies has been suggested as an adjunct/substitute for traditional culture. We have shown that CMV-polymerase chain reaction of AF is a useful diagnostic test for congenital CMV infection. Using this test we diagnosed CMV infection in the fetus of a 30-year-old renal transplant recipient. As termination was not an option for the family, the patient was extensively counseled and treated with oral ganciclovir. This resulted in clearance of the virus from the AF and the delivery of a healthy newborn girl, free of CMV disease. This is the first reported case to our knowledge of successful use of maternal ganciclovir to treat intrauterine CMV infection in a pregnant renal transplant recipient.

(PDF emailed within 0-6 h: $19.90)

Accession: 050444983

Download citation: RISBibTeXText

PMID: 16150094

DOI: 10.1111/j.1399-3062.2005.00089.x


Related references

Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient. Transplant Infectious Disease 10(2): 123-128, 2007

Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction. American Journal of Transplantation 2(7): 671-673, 2002

Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report. Nephrology 21 Suppl 1: 63-66, 2017

Successful ganciclovir treatment of primary cytomegalovirus infection containing the UL97 mutation N510S in an intestinal graft recipient. Infection 41(4): 875-879, 2013

Emergence of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient. Transplantation Proceedings 32(2): 407, 2000

Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient. Transplantation 69(1): 182-184, 2000

Successful treatment for active cytomegalovirus infection by cytomegalovirus antibody-enriched immunoglobulin in a renal transplant recipient. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 71(12): 1257-1260, 1998

Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report. Annals of Transplantation 19: 60-63, 2014

Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient. Transplantation 75(5): 724-727, 2003

Successful use of oral valacyclovir in post-transplant cytomegalovirus infection in renal allograft recipients. Nephrology, Dialysis, Transplantation 13(5): 1326-1327, 1998

Viral deletion of the UL 97 gene detected in a gastric biopsy in a renal allograft recipient with cytomegalovirus esophagitis and gastritis and ganciclovir resistance. Journal of the American Society of Nephrology 14(Abstracts Issue): 425A, 2003

Ganciclovir for cytomegalovirus cmv infection in renal allograft recipients. Journal of Urology 145(4 SUPPL): 304A, 1991

Treatment of active CMV infection with oral ganciclovir in renal allograft recipients Monitoring efficacy with quantitative CMV-PCR. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 719A-720A, 2000

Treatment of active CMV infection in renal allograft recipients with oral ganciclovir Monitoring efficacy using quantitative CMV-PCR. Journal of Investigative Medicine 49(1): 48A, 2001

Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplantation Proceedings 23(1 Pt 2): 1346-1347, 1991